+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Granuloma Inguinale Diagnostics Market 2024: US, Europe, Japan - Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies

  • PDF Icon

    Report

  • August 2024
  • Region: Europe, Japan, United States
  • VPG Market Research
  • ID: 5995537
Description Jump to:
The report presents a detailed analysis of the diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on definition, epidemiology and etiology are reviewed.

The report provides the 5-year test volume and sales forecasts by country for the following market segments:
  • Hospitals
  • Commercial/Private Labs
  • Physician Offices
  • Public Health Labs

Related Topics

Related Reports

2024-2028 Global Granuloma Inguinale Testing in 90 Countries: Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation - Product Image

2024-2028 Global Granuloma Inguinale Testing in 90 Countries: Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

  • Report
  • Global
From
2024-2029 Global Hepatitis Diagnostic Market for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT Tests: US, Europe, Japan - Product Image

2024-2029 Global Hepatitis Diagnostic Market for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT Tests: US, Europe, Japan

  • Report
  • Europe, Global, Japan, ... Europe, Global, Japan, United States
From
E-coli Testing Market Size, Share & Trends Analysis Report by Test (Environmental Test, and Clinical Test), End User (Diagnostic Laboratories, Hospitals, and Physicians Offices), Regional Outlook and Forecast, 2024-2031 - Product Image

E-coli Testing Market Size, Share & Trends Analysis Report by Test (Environmental Test, and Clinical Test), End User (Diagnostic Laboratories, Hospitals, and Physicians Offices), Regional Outlook and Forecast, 2024-2031

  • Report
  • 161 Pages
  • Global
From
Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 2-Volume Set. Edition No. 9 - Product Image

Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 2-Volume Set. Edition No. 9

  • Book
Allergy Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Allergy Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From

About the Granuloma Inguinale Diagnostic Market

Granuloma Inguinale Diagnostic is a type of diagnostic test used to detect the presence of granuloma inguinale, a sexually transmitted infection caused by the bacterium Calymmatobacterium granulomatis. The infection is characterized by the presence of small, painless ulcers on the genitals, and can be difficult to diagnose due to its similarity to other sexually transmitted infections. Diagnosis is typically made through a physical examination and laboratory testing, including a polymerase chain reaction (PCR) test. Treatment typically involves antibiotics, and can be effective if started early. Companies in the Granuloma Inguinale Diagnostic market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.